Week of April 24: 134 people in 65-74 age group are estimated to have died in Oklahoma

Week of April 24: 134 people in 65-74 age group are estimated to have died in Oklahoma
0Comments

The Centers for Disease Control and Prevention estimates that 134 people in the 65-74 age group died during the week ending April 24.

According to the CDC, only 60% of deaths are reported within the first 10 days. Due to this lag, the CDC provides a predicted number for the most recent weeks. So far, the total reported deaths for the age group 65-74 during that week is 110.

While a lag in death reporting is normal, some use it for more nefarious reasons. In a statement by the Office of the Inspector General, they state that using someone’s benefits after they die is a federal crime. In that same statement, they point to a recent case in which a daughter continued to receive her father’s benefits for 18 years after his death. In March 2019, she ended up being sentenced to jail time and ordered to repay the benefits.

Figures accurate as of May 13.

Deaths by age group – unweighted vs predicted (Week of April 24)



Related

Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs of FDA

Creek County cities: 3 companies received FDA inspections in 2025

There were three companies in cities associated with Creek County that received three FDA inspections in 2025, according to the U.S. Food and Drug Administration.

Melanie Keller, Deputy Commissioner for Operations and Chief Operating Officer of FDA

1 company in a city within Okmulgee County received one inspection in 2025

There was one company in a city associated with Okmulgee County that received an FDA inspection in 2025, according to the U.S. Food and Drug Administration.

Sara Brenner, Principal Deputy Commissioner at FDA

How many companies were inspected by the FDA in cities located in Muskogee County in 2025?

There was one company in a city associated with Muskogee County that received an FDA inspection in 2025, according to the U.S. Food and Drug Administration.